Harmony Biosciences Holdings, Inc. Common Stock (HRMY) — Analysis Summary
Harmony Biosciences Holdings, Inc. Common Stock (HRMY) has a market cap of $1.84B with year-over-year revenue growth of +22.8%. Net margin stands at 20.4%. The stock trades at a P/E ratio of 12.7.
Key Takeaways
- Revenue changed +22.8% year-over-year
- Net margin of 20.4%
- P/E ratio of 12.7
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, HRMY posted revenue growth of +22.8% and trades at a P/E of 12.7.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.